Mon panier

Glypican 2

Glypican 2 Informations sur la molécule

Nom anglaisGlypican-2Nombre de médicaments commercialisés0
Nombre de médicaments cliniques2Alias de la cibleCerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
Phase de R&D la plus avancéePhase 1 Clinical
Nom anglaisGlypican-2
Alias de la cibleCerebroglycan,Glypican Proteoglycan 2, Cerebroglycan Proteoglycan
Nombre de médicaments commercialisés0
Nombre de médicaments cliniques2
Phase de R&D la plus avancéePhase 1 Clinical

Glypican 2 Liste de produits

  • Attribut

    Protein (7)

  • Bibliothèque de produits

    En ligne (7)

  • Espèces

    Human (4)Mouse (1)Rhesus macaque (2)

  • Étiquette

    His Tag (3)Fc Tag (1)Llama IgG Fc Tag (1)His Tag & Avi Tag (2)

  • Marqueur

    Unconjugated (5)Biotin-labeled (2)

Glypican 2Contexte de la molécule

Glypican 2 (GPC2), also known cerebroglycan, is a glycophosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found in the developing nervous system. Cerebroglycan participates in cell adhesion and is thought to regulate the growth and guidance of axons. Cerebroglycan has especially high affinity for laminin-1. GPC2 silencing inactivates Wnt/β-catenin signaling and reduces the expression of N-Myc, an oncogenic driver of neuroblastoma tumorigenesis. Immunotoxins and chimeric antigen receptor (CAR) T cells targeting GPC2 inhibit neuroblastoma growth in mouse models. A GPC3 specific antibody drug conjugate (ADC) can also inhibit neuroblastoma cell proliferation.

Glypican 2Alias de la molécule

Glypican 2,GPC2

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
anti-glypican-2 CAR T-cell therapy (Childrens Hospital of Philadelphia/Kite Pharma)Phase 1 ClinicalChildrens Hospital of PhiladelphiaRhabdomyosarcoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
Details
GPC2 CAR-T cell therapy(Childrens Hospital of Philadelphia/Tmunity Therapeutics)TmGPC2-01-CAR-TPhase 1 ClinicalChildrens Hospital of PhiladelphiaSmall Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma
Details
  • Informations sur la molécule
  • Liste de produits
  • Informations sur les médicaments cliniques